These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8439222)

  • 21. Laboratory monitoring of oral anticoagulant therapy.
    Ginsberg JS; Hirsh J
    Hematol Pathol; 1989; 3(4):147-51. PubMed ID: 2697715
    [No Abstract]   [Full Text] [Related]  

  • 22. Knowledge base of clinicians regarding oral anticoagulant therapy in a teaching institution--a questionnaire survey.
    Kakkar N; Kaur R
    J Assoc Physicians India; 2004 Nov; 52():868-72. PubMed ID: 15906836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of a moderate with moderate-high intensity oral anticoagulant treatment in patients with mechanical heart valve prostheses.
    Pengo V; Barbero F; Banzato A; Garelli E; Noventa F; Biasiolo A; Zasso A; Dalla Volta S
    Thromb Haemost; 1997 May; 77(5):839-44. PubMed ID: 9184389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing outcome measures of oral anticoagulation management in children.
    Jones S; Newall F; Manias E; Monagle P
    Thromb Res; 2011 Feb; 127(2):75-80. PubMed ID: 20888622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
    Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
    Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the efficacy and safety of oral anticoagulant therapy: high-quality dose management, anticoagulation clinics, and patient self-management.
    Ansell JE
    Semin Vasc Med; 2003 Aug; 3(3):261-70. PubMed ID: 15199459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New oral anticoagulants: a brief review.
    Mazza JJ; Yale SH
    WMJ; 2009 Feb; 108(1):35-9. PubMed ID: 19326634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current management of oral anticoagulant treatment].
    Pengo V; Prisco D; Iliceto S
    Ital Heart J Suppl; 2002 May; 3(5):502-17. PubMed ID: 12064189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral anticoagulation treatment--control, risks, benefits, and informed consent].
    Froom P; Hermoni D; Barak M
    Harefuah; 2003 Jan; 142(1):56-60, 77. PubMed ID: 12647491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The debate concerning oral anticoagulation: whether to suspend oral anticoagulants during dental treatment.
    António N; Castro G; Ramos D; Machado A; Gonçalves L; Macedo T; Providência LA
    Rev Port Cardiol; 2008 Apr; 27(4):531-44. PubMed ID: 18605071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral anticoagulant therapy: clinical aspects].
    Marisavljević D
    Srp Arh Celok Lek; 2007; 135(5-6):352-9. PubMed ID: 17633328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dental extractions in patients taking anticoagulants: is alteration of the anticoagulant regime necessary?].
    Madrid C
    Rev Med Suisse; 2005 May; 1(21):1418, 1421-2, 1424. PubMed ID: 15997980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.
    Anderson DR; Fernandez LA
    Can Fam Physician; 1993 Feb; 39():290-4, 297-300, 303-4. PubMed ID: 8495120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A quarter of a century of computer-assisted anticoagulant treatment].
    Visser J
    Ned Tijdschr Geneeskd; 1997 Jan; 141(1):55-7. PubMed ID: 9162853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ximelagatran: a new type of oral anticoagulant.
    Kwok L; Molckovsky D; Boucher M
    Int J Technol Assess Health Care; 2005; 21(4):480-6. PubMed ID: 16262971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral anticoagulant therapy: practical aspects of management.
    Brigden ML
    Postgrad Med; 1996 Jun; 99(6):81-4, 87-9, 93-4 passim. PubMed ID: 8668640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epistaxis and oral anticoagulant therapy.
    Choudhury N; Sharp HR; Mir N; Salama NY
    Rhinology; 2004 Jun; 42(2):92-7. PubMed ID: 15224636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confusion over the therapeutic range for monitoring oral anticoagulant therapy in North America.
    Hirsh J; Levine M
    Thromb Haemost; 1988 Apr; 59(2):129-32. PubMed ID: 3291180
    [No Abstract]   [Full Text] [Related]  

  • 40. [Practical problems of anticoagulant therapy].
    Müller G; Koller F
    Schweiz Rundsch Med Prax; 1970 Apr; 59(16):575-9. PubMed ID: 5519715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.